DNA methylation in the rat livers induced by low dosage isoniazid treatment

Environmental Toxicology and Pharmacology

Volumn 32, Issue 3, 2011, Pages 486-490

  Zhang, Bing ^a,b   Sun, Shufeng ^a   Shen, Lihong ^c   Zu, Xiangyu ^a   Chen, Yi ^a   Hao, Jinqi ^a   Huang, Xiaolin ^a   Feng, Fumin ^a  

^a NORTH CHINA COAL MEDICAL COLLEGE   (China)

^b TANGSHAN PEOPLE S HOSPITAL   (China)

^c HEBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

Anti tuberculosis drug induced hepatotoxicity; DNA methylation; Isoniazid; LINE 1

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC DNA; ISONIAZID; WATER;

ADVERSE OUTCOME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; DRUG EFFECT; DRUG SAFETY; GENE SEQUENCE; GENOME ANALYSIS; LIVER INJURY; LIVER TOXICITY; LONG INTERSPERSED REPEAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTITUBERCULAR AGENTS; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; ISONIAZID; LIVER; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 80054097781     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.07.001     Document Type: Article

References (19)

1. Barros S.P., Offenbacher S. Epigenetics: connecting environment and genotype to phenotype and disease. J. Dent. Res. 2009, 88:400-408.
2. CDC Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008. MMWR Morb. Mortal Wkly. Rep. 2010, 59:224-225.
3. Cruickshanks H.A., Tufarelli C. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics 2009, 94:397-406.
4. de Souza C.T., Hokerberg Y.H., Pacheco S.J., Rolla V.C., Passos S.R. Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro. Mem. Inst. Oswaldo Cruz 2009, 104:462-467.
5. Gomez A., Ingelman-Sundberg M. Pharmacoepigenetics: its role in interindividual differences in drug response. Clin. Pharmacol. Ther. 2009, 85:426-430.
6. Han D., Shinohara M., Ybanez M.D., Saberi B., Kaplowitz N. Signal transduction pathways involved in drug-induced liver injury. Handb. Exp. Pharmacol. 2010, 196:267-310.
7. Hashimoto K., Oreffo R.O., Gibson M.B., Goldring M.B., Roach H.I. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 2009, 60:3303-3313.
8. Hirode M., Horinouchi A., Uehara T., Ono A., Miyagishima T., Yamada H., Nagao T., Ohno Y., Urushidani T. Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. Hum. Exp. Toxicol. 2009, 28:231-244.
9. Kovalenko V.M., Bagnyukova T.V., Sergienko O.V., Bondarenko L.B., Shayakhmetova G.M., Matvienko A.V., Pogribny I.P. Epigenetic changes in the rat livers induced by pyrazinamide treatment. Toxicol. Appl. Pharmacol. 2007, 225:293-299.
10. Lo P.K., Watanabe H., Cheng P.C., Teo W.W., Liang X., Argani P., Lee J.S., Sukumar S. MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density. J. Mol. Diagn. 2009, 11:400-414.
11. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457:36-37.
12. Matsui T., Leung D., Miyashita H., Maksakova I.A., Miyachi H., Kimura H., Tachibana M., Lorincz M.C., Shinkai Y. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010, 464:927-931.
13. Nie A.Y., McMillian M., Parker J.B., Leone A., Bryant S., Yieh L., Bittner A., Nelson J., Carmen A., Wan J., Lord P.G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 2006, 45:914-933.
14. Ramsahoye B.H. Measurement of genome wide DNA methylation by reversed-phase high-performance liquid chromatography. Methods 2002, 27:156-161.
15. Schulz W.A., Steinhoff C., Florl A.R. Methylation of endogenous human retroelements in health and disease. Curr. Top. Microbiol. Immunol. 2006, 310:211-250.
16. Singh N., Golani A., Patel Z., Maitra A. Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosis. Br. J. Clin. Pharmacol. 2008, 65:418-422.
17. Takahashi H., Ogata H., Nishigaki R., Broide D.H., Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKβ- and JNK1-dependent inflammation. Cancer Cell 2010, 17:89-97.
18. Tostmann A., Boeree M.J., Aarnoutse R.E., de Lange W.C., van der Ven A.J., Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J. Gastroenterol. Hepatol. 2008, 23:192-202.
19. Tryndyak V.P., Kovalchuk O., Muskhelishvili L., Montgomery B., Rodriguez-Juarez R., Melnyk S., Ross S.A., Beland F.A., Pogribny I.P. Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol. Carcinog. 2007, 46:187-197.